PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Oxford Biomedica earns U.K. nod for 4th manufacturing suite to boost COVID-19 production

Among the contract manufacturers enjoined in the race for a COVID-19 vaccine, Oxford Biomedica has forged a close relationship with AstraZeneca given its choice loca...
Continue Reading →
News

Sunovion illustrates bipolar depression patients’ emotions with art-driven Latuda spot

Sunovion Pharmaceuticals turned to artwork for its latest Latuda TV commercial. Paintings inspired by real stories of people with bipolar depression are held by acto...
Continue Reading →
News

U.K. manufacturer Abzena pumps $60M into new biologics facility in San Diego

The biologics market has been a bustling one in recent years, with some of the biggest players in the contract manufacturing field dropping 10-figure down payments o...
Continue Reading →
News

Regeneron follows Lilly in asking for emergency approval of COVID-19 antibody drug

Regeneron has requested an emergency clearance from the Food and Drug Administration for its experimental antibody drug for COVID-19, hours after rival Eli Lilly too...
Continue Reading →
News

Natoli to Help Set a Global Standard of Efficiency Called The Natoli Advantage

St. Charles, MO (October 13, 2020)—Natoli Engineering provides a program to help set a global standard of efficiency called The Natoli Advantage. The Natoli Advantag...
Continue Reading →
News

AZ’s long-acting COVID-19 antibody moves into phase III

AstraZeneca’s long-acting antibody (LAAB) combination AZD7442 for the treatment of COVID-19 is set to advance in two phase III clinical trials in the next few weeks....
Continue Reading →
News

EMA accepts filing for Biogen/Samsung Bioepis’ Lucentis biosimilar

The European Medicines Agency (EMA) has accepted for review the marketing authorisation for Biogen and Samsung Bioepis’ biosimilar referencing Genentech's Lucentis (...
Continue Reading →
News

Merck KGaA out-licenses osteoarthritis programme to Novartis

Germany’s Merck KGaA has entered into an out-licensing agreement with Novartis for the development of an osteoarthritis clinical-stage programme. The agreement cov...
Continue Reading →
News

Gilead inks supply agreement with the European Commission for remdesivir

Gilead has signed a joint procurement agreement with the European Commission (EC) to enable ‘rapid and equitable’ access to its COVID-19 antiviral remdesivir, sold u...
Continue Reading →
News

BMS’ Zeposia hits the mark in ulcerative colitis

Bristol Myers Squibb’s oral S1P receptor modulator Zeposia hit both primary endpoints in a phase III trial as an induction and maintenance therapy in adult patients ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026